nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—CHRM5—Tiotropium—chronic obstructive pulmonary disease	0.278	0.369	CbGbCtD
Glycopyrrolate—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.178	0.236	CbGbCtD
Glycopyrrolate—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.154	0.205	CbGbCtD
Glycopyrrolate—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.142	0.189	CbGbCtD
Glycopyrrolate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000513	0.00215	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000513	0.00215	CcSEcCtD
Glycopyrrolate—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000513	0.00215	CcSEcCtD
Glycopyrrolate—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000513	0.00215	CcSEcCtD
Glycopyrrolate—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000513	0.00215	CcSEcCtD
Glycopyrrolate—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000512	0.00215	CcSEcCtD
Glycopyrrolate—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000511	0.00214	CcSEcCtD
Glycopyrrolate—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00051	0.00214	CcSEcCtD
Glycopyrrolate—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00051	0.00214	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000505	0.00212	CcSEcCtD
Glycopyrrolate—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000503	0.00211	CcSEcCtD
Glycopyrrolate—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000502	0.00211	CcSEcCtD
Glycopyrrolate—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.0005	0.0021	CcSEcCtD
Glycopyrrolate—Tension—Arformoterol—chronic obstructive pulmonary disease	0.0005	0.0021	CcSEcCtD
Glycopyrrolate—Tension—Formoterol—chronic obstructive pulmonary disease	0.0005	0.0021	CcSEcCtD
Glycopyrrolate—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000499	0.00209	CcSEcCtD
Glycopyrrolate—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000499	0.00209	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000498	0.00209	CcSEcCtD
Glycopyrrolate—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000495	0.00207	CcSEcCtD
Glycopyrrolate—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000495	0.00207	CcSEcCtD
Glycopyrrolate—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000494	0.00207	CcSEcCtD
Glycopyrrolate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000487	0.00204	CcSEcCtD
Glycopyrrolate—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000484	0.00203	CcSEcCtD
Glycopyrrolate—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00202	CcSEcCtD
Glycopyrrolate—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000481	0.00202	CcSEcCtD
Glycopyrrolate—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000474	0.00199	CcSEcCtD
Glycopyrrolate—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000473	0.00198	CcSEcCtD
Glycopyrrolate—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000472	0.00198	CcSEcCtD
Glycopyrrolate—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000471	0.00197	CcSEcCtD
Glycopyrrolate—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000468	0.00196	CcSEcCtD
Glycopyrrolate—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000468	0.00196	CcSEcCtD
Glycopyrrolate—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000467	0.00196	CcSEcCtD
Glycopyrrolate—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000466	0.00195	CcSEcCtD
Glycopyrrolate—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000459	0.00192	CcSEcCtD
Glycopyrrolate—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000454	0.0019	CcSEcCtD
Glycopyrrolate—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000451	0.00189	CcSEcCtD
Glycopyrrolate—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00045	0.00189	CcSEcCtD
Glycopyrrolate—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00045	0.00189	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000447	0.00187	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000445	0.00186	CcSEcCtD
Glycopyrrolate—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000442	0.00185	CcSEcCtD
Glycopyrrolate—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000441	0.00185	CcSEcCtD
Glycopyrrolate—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000441	0.00185	CcSEcCtD
Glycopyrrolate—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00044	0.00184	CcSEcCtD
Glycopyrrolate—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00044	0.00184	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000436	0.00183	CcSEcCtD
Glycopyrrolate—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000434	0.00182	CcSEcCtD
Glycopyrrolate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000434	0.00182	CcSEcCtD
Glycopyrrolate—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000432	0.00181	CcSEcCtD
Glycopyrrolate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000432	0.00181	CcSEcCtD
Glycopyrrolate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000432	0.00181	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000431	0.00181	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000431	0.00181	CcSEcCtD
Glycopyrrolate—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000425	0.00178	CcSEcCtD
Glycopyrrolate—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000424	0.00178	CcSEcCtD
Glycopyrrolate—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000424	0.00178	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000422	0.00177	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000421	0.00177	CcSEcCtD
Glycopyrrolate—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00042	0.00176	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00174	CcSEcCtD
Glycopyrrolate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00174	CcSEcCtD
Glycopyrrolate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00174	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00174	CcSEcCtD
Glycopyrrolate—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.00174	CcSEcCtD
Glycopyrrolate—Infection—Formoterol—chronic obstructive pulmonary disease	0.000413	0.00173	CcSEcCtD
Glycopyrrolate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000413	0.00173	CcSEcCtD
Glycopyrrolate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000409	0.00172	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000408	0.00171	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000408	0.00171	CcSEcCtD
Glycopyrrolate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000407	0.00171	CcSEcCtD
Glycopyrrolate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000407	0.00171	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000407	0.00171	CcSEcCtD
Glycopyrrolate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000406	0.0017	CcSEcCtD
Glycopyrrolate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000406	0.0017	CcSEcCtD
Glycopyrrolate—Infection—Montelukast—chronic obstructive pulmonary disease	0.000405	0.0017	CcSEcCtD
Glycopyrrolate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000404	0.00169	CcSEcCtD
Glycopyrrolate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000404	0.00169	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000403	0.00169	CcSEcCtD
Glycopyrrolate—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000401	0.00168	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000399	0.00167	CcSEcCtD
Glycopyrrolate—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000399	0.00167	CcSEcCtD
Glycopyrrolate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000396	0.00166	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00165	CcSEcCtD
Glycopyrrolate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00165	CcSEcCtD
Glycopyrrolate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00039	0.00163	CcSEcCtD
Glycopyrrolate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000389	0.00163	CcSEcCtD
Glycopyrrolate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000389	0.00163	CcSEcCtD
Glycopyrrolate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000387	0.00162	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.00161	CcSEcCtD
Glycopyrrolate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000383	0.00161	CcSEcCtD
Glycopyrrolate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000381	0.0016	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00038	0.00159	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00159	CcSEcCtD
Glycopyrrolate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000376	0.00158	CcSEcCtD
Glycopyrrolate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000376	0.00158	CcSEcCtD
Glycopyrrolate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00037	0.00155	CcSEcCtD
Glycopyrrolate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00037	0.00155	CcSEcCtD
Glycopyrrolate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000368	0.00154	CcSEcCtD
Glycopyrrolate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000367	0.00154	CcSEcCtD
Glycopyrrolate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.00153	CcSEcCtD
Glycopyrrolate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000366	0.00153	CcSEcCtD
Glycopyrrolate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000365	0.00153	CcSEcCtD
Glycopyrrolate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000362	0.00152	CcSEcCtD
Glycopyrrolate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000361	0.00151	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000359	0.0015	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.0015	CcSEcCtD
Glycopyrrolate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000359	0.0015	CcSEcCtD
Glycopyrrolate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000359	0.0015	CcSEcCtD
Glycopyrrolate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.0015	CcSEcCtD
Glycopyrrolate—Pain—Formoterol—chronic obstructive pulmonary disease	0.000356	0.00149	CcSEcCtD
Glycopyrrolate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000356	0.00149	CcSEcCtD
Glycopyrrolate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000356	0.00149	CcSEcCtD
Glycopyrrolate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000356	0.00149	CcSEcCtD
Glycopyrrolate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000355	0.00149	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000352	0.00147	CcSEcCtD
Glycopyrrolate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000351	0.00147	CcSEcCtD
Glycopyrrolate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.00146	CcSEcCtD
Glycopyrrolate—Pain—Montelukast—chronic obstructive pulmonary disease	0.000348	0.00146	CcSEcCtD
Glycopyrrolate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000347	0.00146	CcSEcCtD
Glycopyrrolate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.00145	CcSEcCtD
Glycopyrrolate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000344	0.00144	CcSEcCtD
Glycopyrrolate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000344	0.00144	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000343	0.00144	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.00144	CcSEcCtD
Glycopyrrolate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000342	0.00143	CcSEcCtD
Glycopyrrolate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000341	0.00143	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00034	0.00143	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00034	0.00143	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00142	CcSEcCtD
Glycopyrrolate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00142	CcSEcCtD
Glycopyrrolate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000336	0.00141	CcSEcCtD
Glycopyrrolate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000336	0.00141	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000333	0.0014	CcSEcCtD
Glycopyrrolate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00138	CcSEcCtD
Glycopyrrolate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00138	CcSEcCtD
Glycopyrrolate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000329	0.00138	CcSEcCtD
Glycopyrrolate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000329	0.00138	CcSEcCtD
Glycopyrrolate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000329	0.00138	CcSEcCtD
Glycopyrrolate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000329	0.00138	CcSEcCtD
Glycopyrrolate—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000328	0.00137	CcSEcCtD
Glycopyrrolate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000328	0.00137	CcSEcCtD
Glycopyrrolate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000325	0.00136	CcSEcCtD
Glycopyrrolate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000325	0.00136	CcSEcCtD
Glycopyrrolate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000325	0.00136	CcSEcCtD
Glycopyrrolate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000324	0.00136	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00136	CcSEcCtD
Glycopyrrolate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000323	0.00135	CcSEcCtD
Glycopyrrolate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000322	0.00135	CcSEcCtD
Glycopyrrolate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000322	0.00135	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00135	CcSEcCtD
Glycopyrrolate—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000318	0.00133	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000317	0.00133	CcSEcCtD
Glycopyrrolate—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000315	0.00132	CcSEcCtD
Glycopyrrolate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.00131	CcSEcCtD
Glycopyrrolate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.0013	CcSEcCtD
Glycopyrrolate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.0013	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00128	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00128	CcSEcCtD
Glycopyrrolate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000306	0.00128	CcSEcCtD
Glycopyrrolate—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000305	0.00128	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00126	CcSEcCtD
Glycopyrrolate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00125	CcSEcCtD
Glycopyrrolate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00125	CcSEcCtD
Glycopyrrolate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00123	CcSEcCtD
Glycopyrrolate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00123	CcSEcCtD
Glycopyrrolate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000292	0.00122	CcSEcCtD
Glycopyrrolate—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00029	0.00121	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00121	CcSEcCtD
Glycopyrrolate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000288	0.00121	CcSEcCtD
Glycopyrrolate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00118	CcSEcCtD
Glycopyrrolate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00116	CcSEcCtD
Glycopyrrolate—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.00116	CcSEcCtD
Glycopyrrolate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00115	CcSEcCtD
Glycopyrrolate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00115	CcSEcCtD
Glycopyrrolate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000269	0.00113	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00111	CcSEcCtD
Glycopyrrolate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000264	0.00111	CcSEcCtD
Glycopyrrolate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.00111	CcSEcCtD
Glycopyrrolate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.0011	CcSEcCtD
Glycopyrrolate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000262	0.0011	CcSEcCtD
Glycopyrrolate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.0011	CcSEcCtD
Glycopyrrolate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000262	0.0011	CcSEcCtD
Glycopyrrolate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00109	CcSEcCtD
Glycopyrrolate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00109	CcSEcCtD
Glycopyrrolate—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00026	0.00109	CcSEcCtD
Glycopyrrolate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00109	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00026	0.00109	CcSEcCtD
Glycopyrrolate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000259	0.00109	CcSEcCtD
Glycopyrrolate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000257	0.00108	CcSEcCtD
Glycopyrrolate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000257	0.00108	CcSEcCtD
Glycopyrrolate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000255	0.00107	CcSEcCtD
Glycopyrrolate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00105	CcSEcCtD
Glycopyrrolate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.00104	CcSEcCtD
Glycopyrrolate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00104	CcSEcCtD
Glycopyrrolate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00104	CcSEcCtD
Glycopyrrolate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00104	CcSEcCtD
Glycopyrrolate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00103	CcSEcCtD
Glycopyrrolate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00101	CcSEcCtD
Glycopyrrolate—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000239	0.001	CcSEcCtD
Glycopyrrolate—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.000998	CcSEcCtD
Glycopyrrolate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.000977	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000226	0.000949	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.000944	CcSEcCtD
Glycopyrrolate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.000944	CcSEcCtD
Glycopyrrolate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00022	0.000921	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.000912	CcSEcCtD
Glycopyrrolate—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000896	CcSEcCtD
Glycopyrrolate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.000854	CcSEcCtD
Glycopyrrolate—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000846	CcSEcCtD
Glycopyrrolate—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00084	CcSEcCtD
Glycopyrrolate—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00084	CcSEcCtD
Glycopyrrolate—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000193	0.000807	CcSEcCtD
Glycopyrrolate—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000792	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.000778	CcSEcCtD
Glycopyrrolate—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000772	CcSEcCtD
Glycopyrrolate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.00075	CcSEcCtD
Glycopyrrolate—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000728	CcSEcCtD
Glycopyrrolate—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000726	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000711	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000695	CcSEcCtD
Glycopyrrolate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000686	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000686	CcSEcCtD
Glycopyrrolate—Infection—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000681	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000673	CcSEcCtD
Glycopyrrolate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000669	CcSEcCtD
Glycopyrrolate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000666	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000663	CcSEcCtD
Glycopyrrolate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000624	CcSEcCtD
Glycopyrrolate—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00062	CcSEcCtD
Glycopyrrolate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000604	CcSEcCtD
Glycopyrrolate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000595	CcSEcCtD
Glycopyrrolate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000595	CcSEcCtD
Glycopyrrolate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000591	CcSEcCtD
Glycopyrrolate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.000591	CcSEcCtD
Glycopyrrolate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000587	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000565	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000561	CcSEcCtD
Glycopyrrolate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000561	CcSEcCtD
Glycopyrrolate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000545	CcSEcCtD
Glycopyrrolate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000542	CcSEcCtD
Glycopyrrolate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000542	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000505	CcSEcCtD
Glycopyrrolate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000492	CcSEcCtD
Glycopyrrolate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000485	CcSEcCtD
Glycopyrrolate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000454	CcSEcCtD
Glycopyrrolate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000436	CcSEcCtD
Glycopyrrolate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000432	CcSEcCtD
Glycopyrrolate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000432	CcSEcCtD
Glycopyrrolate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00043	CcSEcCtD
Glycopyrrolate—Nausea—Prednisone—chronic obstructive pulmonary disease	9.72e-05	0.000407	CcSEcCtD
Glycopyrrolate—CHRM2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	3.11e-05	0.00343	CbGpPWpGaD
Glycopyrrolate—CHRM1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	3.06e-05	0.00338	CbGpPWpGaD
Glycopyrrolate—CHRM3—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	3.05e-05	0.00337	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	3.03e-05	0.00334	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	3.02e-05	0.00333	CbGpPWpGaD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.01e-05	0.00332	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	2.99e-05	0.0033	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.98e-05	0.00328	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.93e-05	0.00323	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.88e-05	0.00318	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.85e-05	0.00314	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—APIP—chronic obstructive pulmonary disease	2.81e-05	0.0031	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.81e-05	0.0031	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	2.74e-05	0.00302	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	2.73e-05	0.00301	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	2.69e-05	0.00297	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.64e-05	0.00291	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.62e-05	0.00289	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.6e-05	0.00286	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.59e-05	0.00285	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.58e-05	0.00285	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.57e-05	0.00284	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.56e-05	0.00283	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.55e-05	0.00281	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.53e-05	0.00279	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.51e-05	0.00277	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	2.51e-05	0.00276	CbGpPWpGaD
Glycopyrrolate—CHRM4—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	2.46e-05	0.00271	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.4e-05	0.00265	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.37e-05	0.00261	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.36e-05	0.0026	CbGpPWpGaD
Glycopyrrolate—CHRM5—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	2.36e-05	0.0026	CbGpPWpGaD
Glycopyrrolate—CHRM4—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	2.34e-05	0.00258	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.34e-05	0.00258	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.32e-05	0.00256	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.32e-05	0.00256	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.31e-05	0.00255	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.3e-05	0.00253	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.29e-05	0.00253	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.29e-05	0.00253	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.22e-05	0.00245	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.21e-05	0.00244	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.2e-05	0.00243	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.19e-05	0.00242	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.18e-05	0.00241	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	2.16e-05	0.00238	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	2.11e-05	0.00233	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	2.07e-05	0.00229	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.03e-05	0.00224	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.02e-05	0.00223	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.01e-05	0.00221	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2e-05	0.00221	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2e-05	0.00221	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.98e-05	0.00218	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.98e-05	0.00218	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.97e-05	0.00217	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.95e-05	0.00215	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.86e-05	0.00206	CbGpPWpGaD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.86e-05	0.00205	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GC—chronic obstructive pulmonary disease	1.81e-05	0.002	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.78e-05	0.00196	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.78e-05	0.00196	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.77e-05	0.00196	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.77e-05	0.00195	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.76e-05	0.00194	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.76e-05	0.00194	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.76e-05	0.00194	CbGpPWpGaD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.76e-05	0.00194	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	1.75e-05	0.00194	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.74e-05	0.00192	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.69e-05	0.00186	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.68e-05	0.00186	CbGpPWpGaD
Glycopyrrolate—CHRM1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.66e-05	0.00183	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.66e-05	0.00183	CbGpPWpGaD
Glycopyrrolate—CHRM3—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.65e-05	0.00182	CbGpPWpGaD
Glycopyrrolate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.64e-05	0.00181	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.62e-05	0.00178	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.61e-05	0.00178	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.6e-05	0.00176	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.59e-05	0.00175	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.56e-05	0.00173	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.56e-05	0.00172	CbGpPWpGaD
Glycopyrrolate—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	1.56e-05	0.00172	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.55e-05	0.0017	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.54e-05	0.0017	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.54e-05	0.0017	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.53e-05	0.00168	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.5e-05	0.00166	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	1.5e-05	0.00166	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.48e-05	0.00163	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.44e-05	0.00159	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.42e-05	0.00156	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.42e-05	0.00156	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.42e-05	0.00156	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.36e-05	0.0015	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.36e-05	0.0015	CbGpPWpGaD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.35e-05	0.00149	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.34e-05	0.00148	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.3e-05	0.00143	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.29e-05	0.00142	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.25e-05	0.00138	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.25e-05	0.00138	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.24e-05	0.00137	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.24e-05	0.00137	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.24e-05	0.00137	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.23e-05	0.00136	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.21e-05	0.00134	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.19e-05	0.00131	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.18e-05	0.0013	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.18e-05	0.0013	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.17e-05	0.00129	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.13e-05	0.00124	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.12e-05	0.00123	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.11e-05	0.00123	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.1e-05	0.00122	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	1.1e-05	0.00121	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.04e-05	0.00114	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.01e-05	0.00112	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.01e-05	0.00112	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	1e-05	0.00111	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1e-05	0.0011	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	9.98e-06	0.0011	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	9.95e-06	0.0011	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.92e-06	0.00109	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.91e-06	0.00109	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	9.85e-06	0.00109	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GCLC—chronic obstructive pulmonary disease	9.79e-06	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.63e-06	0.00106	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.55e-06	0.00105	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.55e-06	0.00105	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.52e-06	0.00105	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.52e-06	0.00105	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	9.51e-06	0.00105	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	9.48e-06	0.00105	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.43e-06	0.00104	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.42e-06	0.00104	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.22e-06	0.00102	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.06e-06	0.001	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.04e-06	0.000997	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.95e-06	0.000987	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CTGF—chronic obstructive pulmonary disease	8.94e-06	0.000986	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.89e-06	0.00098	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.73e-06	0.000963	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.7e-06	0.00096	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.62e-06	0.000951	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.51e-06	0.000939	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.23e-06	0.000908	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8e-06	0.000883	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.94e-06	0.000876	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.93e-06	0.000875	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.9e-06	0.000872	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.83e-06	0.000864	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.66e-06	0.000845	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.61e-06	0.000839	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.27e-06	0.000802	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.22e-06	0.000796	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.98e-06	0.000771	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.96e-06	0.000768	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.96e-06	0.000768	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.95e-06	0.000766	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.91e-06	0.000763	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.89e-06	0.000761	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.87e-06	0.000758	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.77e-06	0.000747	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.65e-06	0.000734	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.49e-06	0.000716	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.47e-06	0.000714	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.46e-06	0.000713	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.41e-06	0.000707	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.31e-06	0.000696	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.19e-06	0.000682	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.99e-06	0.000661	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.98e-06	0.00066	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.97e-06	0.000659	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.92e-06	0.000653	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.39e-06	0.000595	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.38e-06	0.000593	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.35e-06	0.000591	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.34e-06	0.000589	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.33e-06	0.000588	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.31e-06	0.000586	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.29e-06	0.000583	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.09e-06	0.000561	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.07e-06	0.000559	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.9e-06	0.000541	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.88e-06	0.000539	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.87e-06	0.000537	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.85e-06	0.000535	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.85e-06	0.000535	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.84e-06	0.000534	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.84e-06	0.000534	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.8e-06	0.00053	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.68e-06	0.000517	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.67e-06	0.000515	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.63e-06	0.000511	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.62e-06	0.00051	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.35e-06	0.00048	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.34e-06	0.000479	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.3e-06	0.000474	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.29e-06	0.000474	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.11e-06	0.000453	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.08e-06	0.00045	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	4.07e-06	0.000449	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.91e-06	0.000431	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	3.89e-06	0.000429	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.88e-06	0.000428	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.72e-06	0.00041	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.58e-06	0.000395	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.57e-06	0.000394	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.53e-06	0.00039	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.49e-06	0.000385	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.42e-06	0.000377	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.41e-06	0.000376	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.37e-06	0.000372	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.34e-06	0.000368	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.26e-06	0.00036	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.25e-06	0.000359	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.22e-06	0.000355	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.2e-06	0.000353	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.14e-06	0.000346	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.06e-06	0.000338	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3e-06	0.000331	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.89e-06	0.000319	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.88e-06	0.000318	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.86e-06	0.000315	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.75e-06	0.000304	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.74e-06	0.000303	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.72e-06	0.0003	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.63e-06	0.000291	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.62e-06	0.000289	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.61e-06	0.000288	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.58e-06	0.000285	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.52e-06	0.000278	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.41e-06	0.000266	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.35e-06	0.000259	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.34e-06	0.000259	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.32e-06	0.000256	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.31e-06	0.000255	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.16e-06	0.000238	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.15e-06	0.000237	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.13e-06	0.000235	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.12e-06	0.000233	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.11e-06	0.000233	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.09e-06	0.00023	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.78e-06	0.000196	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.77e-06	0.000195	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.75e-06	0.000193	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.63e-06	0.000179	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.62e-06	0.000179	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.6e-06	0.000177	CbGpPWpGaD
